Navigation Links
Is it really only our kidneys that control blood pressure?
Date:3/13/2009

The problem of high blood pressure has reached pandemic proportions, causing premature death through heart attacks, strokes and kidney disease in a third of the UK population. For decades, scientists have battled at length over its cause yet still cannot agree; is the kidney or the brain to blame?

This month, Experimental Physiology hosts a lively debate between two groups of world-leading experts. In the first ever published dialogue on the topic, Drs Montani & Vliet and Drs Osborn, Averina & Fink share their opinions with us and criticise each-others theories. Their frank exchange of views provides an interesting and informative summary of the latest research into how blood pressure is controlled.

When blood pressure increases the kidneys respond by extracting extra water and salts into the urine, causing blood volume and hence pressure to fall. But special nerve pathways mean the brain can also regulate urine production and hence influence blood pressure. So which organ is really in charge?

Montani & Vliet argue that controlling blood volume is the key, as the kidney automatically makes more urine as blood pressure increases.

However, Osborn and colleagues remind us that the cardiovascular system is controlled by multiple mechanisms including the automatic part of the nervous system, which directly controls the kidney. They also update us on a plethora of new findings supporting a role of the nervous system in controlling blood pressure long term.

But both groups acknowledge that new mathematical models are needed that incorporate both the kidney and the brain control systems. So the question of whether it is the kidney or the brain that has a firmer grip on the reins for controlling blood pressure may have to wait for a mathematician to answer.

Professor David Paterson, the Chief Editor of Experimental Physiology and instigator of the debate, said: "This frank exchange of views was needed as it highlights major issues that remain with blood pressure control and will undoubtedly guide future studies to reveal fundamental new knowledge that will inform the future treatment of high blood pressure."


'/>"/>

Contact: Melanie Thomson
melanie.thomson@wiley.com
44-018-654-76270
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. When is a stem cell not really a stem cell?
2. Early bird project really gets the worm
3. Hot peppers really do bring the heat
4. For the birds or for me? Why do conservationists really help wildlife?
5. What is really happening to the Greenland icecap?
6. Circadian clock controls plant growth hormone
7. Key to out-of-control immune response in lung injury found
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
10. Controlling for size may also prevent cancer
11. UT Southwestern researchers identify hundreds of genes controlling female fertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: